Status: current, Defined. Date: 31-Mar 2015. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3029831000168119 | Lignocaine (Pfizer) 1% (50 mg/5 mL) injection, 50 x 5 mL ampoules | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 3050551000168119 | Lignocaine (Pfizer) (lidocaine hydrochloride monohydrate 50 mg / 5 mL) injection, 50 x 5 mL ampoules (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lignocaine (Pfizer) 1% (50 mg/5 mL) injection, 50 x 5 mL ampoules | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Lignocaine (Pfizer) 1% (50 mg/5 mL) injection, 50 x 5 mL ampoules | Is a | Lignocaine (Pfizer) 1% (50 mg/5 mL) injection, 50 x 5 mL ampoules | true | Inferred relationship | Some | ||
| Lignocaine (Pfizer) 1% (50 mg/5 mL) injection, 50 x 5 mL ampoules | has container type | ampoule | true | Inferred relationship | Some | ||
| Lignocaine (Pfizer) 1% (50 mg/5 mL) injection, 50 x 5 mL ampoules | has TP | Lignocaine (Pfizer) | true | Inferred relationship | Some | ||
| Lignocaine (Pfizer) 1% (50 mg/5 mL) injection, 50 x 5 mL ampoules | has TPUU | Lignocaine (Pfizer) 1% (50 mg/5 mL) injection, 5 mL ampoule | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR